282 related articles for article (PubMed ID: 32855724)
1.
Liu TY; Zhao LL; Chen SB; Hou BC; Huang J; Hong X; Qing L; Fang Y; Tao Z
Exp Ther Med; 2020 Oct; 20(4):3733-3739. PubMed ID: 32855724
[TBL] [Abstract][Full Text] [Related]
2. Polygonatum Polysaccharide Regulates Macrophage Polarization and Improves LPS-Induced Acute Lung Injury through TLR4-MAPK/NF-
Zhou W; Hong J; Liu T; Li M; Jin H; Wang X
Can Respir J; 2022; 2022():2686992. PubMed ID: 35874106
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
7. The Defensive Action of LYRM03 on LPS-Induced Acute Lung Injury by NF-κB/TLR4/NLRP3 Signals.
Wang B; Wang J; Lu D; Qi N; Liu Q
J Invest Surg; 2021 Mar; 34(3):284-296. PubMed ID: 31274341
[TBL] [Abstract][Full Text] [Related]
8. Umbelliferone Alleviates Lipopolysaccharide-Induced Inflammatory Responses in Acute Lung Injury by Down-Regulating TLR4/MyD88/NF-κB Signaling.
Wang D; Wang X; Tong W; Cui Y; Li X; Sun H
Inflammation; 2019 Apr; 42(2):440-448. PubMed ID: 30645708
[TBL] [Abstract][Full Text] [Related]
9. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
10. Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS
Zhang C; Wang X; Wang C; He C; Ma Q; Li J; Wang W; Xu YT; Wang T
Front Pharmacol; 2021; 12():790072. PubMed ID: 35002723
[No Abstract] [Full Text] [Related]
11. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
Feng G; Sun B; Li TZ
Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
[TBL] [Abstract][Full Text] [Related]
12. Posttreatment With LYRM03 Protects Rats From Acute Lung Inflammation Induced by Lipopolysaccharide via Suppressing the NF-κB/MyD88/TLR4 Axis.
Jiang Q; Wang S; Shi Y
J Surg Res; 2019 Nov; 243():316-324. PubMed ID: 31255931
[TBL] [Abstract][Full Text] [Related]
13. Biochanin A protect against lipopolysaccharide-induced acute lung injury in mice by regulating TLR4/NF-κB and PPAR-γ pathway.
Hu X; Qin H; Li Y; Li J; Fu L; Li M; Jiang C; Yun J; Liu Z; Feng Y; Yao Y; Yin B
Microb Pathog; 2020 Jan; 138():103846. PubMed ID: 31698051
[TBL] [Abstract][Full Text] [Related]
14. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of phosphoinositide-dependent kinase 1 (PDK1) inhibits fibrosis and inflammation in lipopolysaccharide-induced acute lung injury rat model by attenuating NF-κB/p65 pathway activation.
Yang K; Li B; Chen J
Ann Transl Med; 2021 Nov; 9(22):1671. PubMed ID: 34988180
[TBL] [Abstract][Full Text] [Related]
16. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
Zhang T; Wang J; Wang S; Ma C
Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
[TBL] [Abstract][Full Text] [Related]
17. Sodium Butyrate Inhibits the Inflammation of Lipopolysaccharide-Induced Acute Lung Injury in Mice by Regulating the Toll-Like Receptor 4/Nuclear Factor κB Signaling Pathway.
Liu J; Chang G; Huang J; Wang Y; Ma N; Roy AC; Shen X
J Agric Food Chem; 2019 Feb; 67(6):1674-1682. PubMed ID: 30661349
[TBL] [Abstract][Full Text] [Related]
18. LPS-RS attenuation of lipopolysaccharide-induced acute lung injury involves NF-κB inhibition.
Abdelmageed ME; El-Awady MS; Abdelrahim M; Suddek GM
Can J Physiol Pharmacol; 2016 Feb; 94(2):140-146. PubMed ID: 26544923
[TBL] [Abstract][Full Text] [Related]
19. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway.
Liu JX; Li X; Yan FG; Pan QJ; Yang C; Wu MY; Li G; Liu HF
Int Immunopharmacol; 2019 Jan; 66():336-346. PubMed ID: 30521962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
